Prognostic significance of HIV-associated oral lesions and their relation to therapy

Oral Diseases

Volumn 8, Issue SUPPL. 2, 2002, Pages 110-114

  Birnbaum, Warren ^a   Hodgson, T A ^b   Reichart, P A ^c   Sherson, W ^d   Nittayannanta, S W ^e   Axell, T E ^f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d United Dental Hospital ^*

^e Sydney Dental Hospital   (Australia)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

AIDS; HIV; Oral lesions; Prognosis

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CONDYLOMA; DEVELOPING COUNTRY; DISEASE COURSE; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LEUKOPLAKIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THRUSH; VIRUS LOAD; ADULT; AIDS RELATED COMPLEX; CHILD; CONDYLOMA ACUMINATUM; DEVELOPED COUNTRY; HEALTH CARE PLANNING; MOUTH DISEASE; MOUTH TUMOR; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDIASIS, ORAL; COMPLICATION; HIV INFECTIONS; LEUKOPLAKIA, HAIRY; MOUTH DISEASES; MOUTH NEOPLASMS; SARCOMA, KAPOSI;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CANDIDIASIS, ORAL; CHILD; CONDYLOMATA ACUMINATA; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISEASE PROGRESSION; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; MOUTH DISEASES; MOUTH NEOPLASMS; PROGNOSIS; SARCOMA, KAPOSI; VIRAL LOAD;

EID: 18744392835     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2002.00021.x     Document Type: Review

References (53)

1. Aguirre JM, Echenbarria MA, Ocina E et al. (1999). Reduction of HIV associated oral lesions after highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88: 114-115.
2. Baqui AAMA, Meiller TF, Jabra-Rizk MA et al. (1999). Association of HIV viral load with oral diseases. Oral Dis 5: 294-298.
3. Begg MD, Lamster IB, Panageas KS et al. (1997). A prospective study of oral lesions and their predictive value for progression of HIV disease. Oral Dis 3: 176-183.
4. Begg MD, Panageas KS, Mitchell-Lewis D et al. (1996). Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82: 276-283.
5. Cauda R, Tacconelli E, Tumbarello M et al. (1999). Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV-infection: a prospective case-control study. JAIDS 21: 20-25.
6. Chan A, Milnes A, King SM et al. (1994). The relationship of oral manifestations to parameters of immune function and CDC stage in children born to HIV positive women. Pediatric AIDS HIV Infection: Fetus Adolescent 5: 101-107.
7. Conant MA, Opp KM, Portez D et al. (1997). Reduction of Kaposi's sarcoma lesions following treatment of AIDS with ritonovir. AIDS 11: 1300-1301.
8. Diz Dios P, Ocampo A, Miralles C et al. (1999). Frequency of oral candidiasis in HIV infected patients on protease inhibitor therapy. Oral Surg Oral Med Oral Pathol 87: 437-441.
9. Dodd CL, Greenspan D, Katz MH et al. (1991). Oral Candidiasis in HIV infection: pseudomembranous and erythematous cand-idiasis show similar rates of progression to AIDS. AIDS 5: 1339-1343.
10. Flaitz CM, Nichols CM, Hicks MJ (1996). Oral malignancies diagnosed in an HIV-dedicated dental clinic. Tex Dent J 113: 49-57.
11. Glick M, Muzyka BC, Lurie D et al. (1994). Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 77: 344-349.
12. Greenspan JS (1997). Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease. Oral Dis 3 (Suppl. 1): S13-S17.
13. Hilton JF (2000). Functions of oral candidiasis episodes that are highly prognostic for AIDS. Stat Med 19: 989-1004.
14. Hodgson TA (1997). HIV-associated oral lesions: prevalence in Zambia. Oral Dis. Supplement 1: S46-S50.
15. Hoegl L, Thoma-Greber E, Röcken M et al. (1998). HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study. Mycoses 41: 321-325.
16. Husak R, Garbe C, Orfanos CE (1996). Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol 35: 928-934.
17. Katz MH, Greenspan D, Westenhouse J et al. (1992). Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 6: 95-100.
18. Katz MH, Mastrucci MT, Leggott PJ et al. (1993). Prognostic significance of oral lesions in children with perinatally acquired human immunodeficiency virus infection. Am J Dis Child 147: 45-48.
19. Klein RS, Harris CA, Small CB et al. (1984). Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 311: 354-358.
20. Kozinetz CA, Carter AB, Simon C et al. (2000). Oral manifestations of pediatric vertical HIV infection. AIDS Patient Care STDS 14: 89-94.
21. Lindan CP, Allen S, Serufilira A et al. (1992). Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 116: 320-328.
22. Lopez DB, Sambuelli R, Femopase F et al. (2000). Bacillary angiomatosis affecting the oral cavity. Report of two cases and review. J Oral Pathol Med 29: 91.
23. Lozada-Nur F, de Sanz S, Silverman S Jr. et al. (1996). Intra-oral non-Hodgkin's lymphoma in seven patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 82: 173-178.
24. Matee MI, Scheutz F, Moshy J (2000). Occurrence of oral lesions in relation to clinical and immunological status among HIV-infected adult Tanzanians. Oral Dis 6: 106-111.
25. + lymphocytes as prognostic markers of HIV-1 infection [see comments]. Ann Intern Med 126: 946-954.
26. Mellors JW, Rinaldo CR, Gupta P et al. (1996). Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272: 1167-1170.
27. Mirowski GW, Hilton JF, Greenspan D et al. (1998). Association of cutaneous and oral diseases in HIV-infected men. Oral Dis 4: 16-21.
28. Moniaci D, Greco D, Flecchia G et al. (1990). Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 19: 477-481.
29. Morfeldt-Manson L, Bottiger B, Nilsson B et al. (1991). Clinical signs and laboratory markers in predicting progression to AIDS in HIV-1 infected patients. Scand J Infect Dis 23: 443-449.
30. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho F et al. (1998). Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse. Br J Dermatol 139: 33-39.
31. Naccache JM, Antoine M, Wislez M (1999). Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med 159: 2009-2013.
32. Nicolatou O, Theodoridou M, Mostrou G et al. (1999). Oral lesions in children with perinatally acquired human immunodeficiency virus infection. J Oral Pathol Med 28: 49-53.
33. Nittayananta W, Chungpanich S, Chanawanna N (2000). Is there any association between the occurrence of oral lesions and systemic diseases. Oral Dis 8(Suppl. 2): 175 [abstract 4].
34. Nittayananta W, Jealae S, Chungpanich S (1997). Oral lesions in Thai heterosexual AIDS patients: a preliminary study. Br Dent J 182: 219-221.
35. Nussenblatt RB, Lane HC (1998). Human immunodeficiency virus disease: changing patterns of intraocular inflammation. Am J Ophthalmol 125: 374-382.
36. Patton LL, McKaig R, Eron JJ Jr. et al. (1999). Oral hairy leukoplakia and oral candidiasis as predictors of HIV viral load. AIDS 13: 2174-2176.
37. Patton LL, McKaig R, Straus R et al. (2000). Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89: 299-304.
38. Patton LL, McKaig RG, Strauss RP et al. (1998). Oral manifestations of HIV in a southeast USA population. Oral Dis 4: 164-169.
39. Phair J, Munoz A, Detels R et al. (1990). The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group [see comments]. N Engl J Med 322: 161-165.
40. Plettenberg A, Reisinger E, Lenzner U et al. (1990). Oral candidosis in HIV-infected patients. Prognostic value and correlation with immunological parameters. Mycoses 33: 421-425.
41. Porter SR, Scully C (1998). HIV topic update: protease inhibitor therapy and oral health care. Oral Dis 4: 159-163.
42. Rabeneck L, Hartigan PM, Huang IW et al. (1991). Predicting outcomes in HIV-infected veterans. II. Survival after AIDS. J Clin Epidemiol 50: 1241-1248.
43. Ramirez-Amador VA, Esquivel-Pedraza L, Ponce dL et al. (1996). Prognostic value of oral candidosis and hairy leukoplakia in 111 Mexican HIV-infected patients. J Oral Pathol Med 25: 206-211.
44. Ramos-Gomez FJ, Hilton JF, Canchola AJ et al. (1996). Risk factors for HIV-related orofacial soft-tissue manifestations in children. Pediatr Dent 18: 121-126.
45. + T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia. J Oral Pathol Med 25: 108-111.
46. Revankar SG, Sanche SE, Dib OP et al. (1998). Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV infected patients. AIDS 12: 2511-2513.
47. Saag MS, Holondniy M, Kurtitzkes DR, O'Brien WA et al. (1996). HIV viral load markers in clinical practice. Nature Med 2: 625-629.
48. Santos R, Cardoso O, Rodrigues P et al. (2000). Bacillary angiomatosis by. Bartonella quintana in an HIV-infected patient. J Am Acad Dermatol 42: 299-301.
49. Schmidt-Westhausen AM, Priepke F, Bergmann FJ et al. (2000). Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 29: 336-341.
50. Schuman P, Ohmit SE, Sobel JD et al. (1998). Oral lesions among women living with or at risk for HIV infection. HIV Epidemiology Research Study (HERS) Group. Am J Med 104: 559-564.
51. Sepkowitz KA (1998). Effect of HAART on natural history of AIDS-related opportunistic disorders. Lancet 351: 228-230.
52. Shiboski CH, Neuhaus JM, Greenspan D et al. (1999). Effect of receptive oral sex and smoking on the incidence of hairy leukoplakia in HIV-positive gay men. J Acquir Immune Defic Syndr 21: 236-242.
53. + cell count. JAMA 279: 35-40.